Robert W. Duggan, Co-Chief Executive Officer at Summit Therapeutics Inc. (SMMT), bought 671,788 shares at $17.68 ($11.9M) on 2025-09-10, disclosed to the SEC on 2025-09-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.68 | 333,394 | $5.9M | 49.6% |
| 2 | $17.68 | 333,394 | $5.9M | 49.6% |
| 3 | $18.07 | 5,000 | $90K | 0.8% |
| Total | $17.68 avg | 671,788 | $11.9M | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |